Fig. 4
From: EMP3 as a prognostic biomarker correlates with EMT in GBM
Individualized predictive models for patients with glioblastoma (A) and (B).The nomogram for predicting 1-, 3- and 5-year overall survival probabilities for glioma patients based on the CGGA and TCGA databases (C) and (D). ROC curve analysis: the accuracy of EMP3 in predicting the prognosis of glioma patients at 1, 3 and 5 years in the CGGA and TCGA databases (E) and (F). Calibration curves for predicting 1-, 3- and 5-year overall survival probabilities for glioma patients using the nomogram method based on the CGGA and TCGA databases